Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Feasibility and implementation of the ASH Research Collaborative's COVID-19 OutcomeS in Myeloma and the Impact of VaCcines (COSMIC): A decentralized, real-world evidence study for patients with multiple myeloma to monitor outcomes related to COVID-19 vaccines and infections
    Meeting Abstract

    Wood, W. A.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Anderson, K. C.; Kumar, S.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Asciminib provides long-term, durable molecular responses in patients with T3151-mutated CML-CP: Final analysis from a phase 1 trial
    Meeting Abstract

    Cortes, J. E.; Rea, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M. W.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma - International, multi-center real-world experience
    Meeting Abstract

    Luttwak, E.; Kambhampati, S.; Drill, E.; Ganesan, N.; Hofstetter, L.; Gurion, R.; Aumann, S.; Haran, A.; Geva, M.; Panossian, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of broad-spectrum antibiotic exposure on CAR-T therapy outcomes in B-cell lymphoma: A multicenter international study
    Meeting Abstract

    Shouval, R.; Fei, T.; Gabrielli, G.; Smith, N. G.; Ghilardi, G.; Slingerland, J.; Peled, J. U.; Taur, Y.; Nasta, S. D.; Luna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Leukemiaphysician's perspective on transplant in patients with TP53 mutated acute myeloid leukemia
    Meeting Abstract

    Vanegas, Y. A. M.; El Khatib, S. Y. M.; Hisrich, B.; Coltoff, A.; Shallis, R. M.; Patel, A. A.; Bewersdorf, J. P.; Oh, T. S.; Abaza, Y.; Foucar, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy demonstrates encouraging activity and a manageable safety profile in patients with heavily pre-treated relapsed or refractory mantle cell lymphoma
    Meeting Abstract

    Budde, E. L.; Matasar, M.; Sehn, L. H.; Assouline, S. E.; Kuruvilla, J.; Flinn, I. W.; Yoon, S. S.; Bosch, F.; Greenwald, D.; Gutierrez, N. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Crebbp inhibition potentiates JAK2 inhibition in post-MPN acute myeloid leukemia
    Meeting Abstract

    Bertulfo, K.; Miller, H.; Najac, R.; Castelan, J. C.; Ma, C.; Debackere, K.; Xiao, W.; Rampal, R.; Levine, R. L.; Lu, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Single-cell spatial transcriptomics identifies lymphoid aggregates with location-specific alterations of adaptive immune cells in human MDS bone marrow
    Meeting Abstract

    Stanley, R.; Zhang, B.; Argyropoulos, K.; Gipson, B.; Weis, K.; Lewis, A. M.; Katsamakis, Z.; Zhao, K.; Snopkowski, C.; Zatzman, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • A single cell atlas of follicular lymphoma across clinical stages defines tumor B cell archetypes, immune microenvironment heterogeneity and novel cell states associated with high-risk FL
    Meeting Abstract

    Sarrabay, A.; Baaklini, S.; Barthelemy, C.; Gil, L.; Beyou, A.; Dahbi, L.; Mossadegh-Keller, N.; Huber, C.; Navarro, J. M.; Salles, G.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of brexucabtagene autoleucel for relapsed/refractory B-cell acute lymphoblastic leukemia in patients aged 60 and above
    Meeting Abstract

    Muhsen, I.; Advani, A. S.; Roloff, G. W.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Grunwald, M. R.; Kota, V. K.; Boccucci, J.; more...
    Blood (2024)

    Fulltext@MSK | Save